CardioRenal receives FDA Breakthrough Device Designation for TENOR
© CardioRenal
Carthera announces positive outcome of End-of-Phase 2 meeting with FDA for SonoCloud-9 system for treatment of recurrent glioblastoma
Genoscience Pharma receives FDA Orphan Drug Designation for ezurpimtrostat to treat HepatoCellular Carcinoma (HCC)
Isorg’s FAP30 optical fingerprint sensor obtains FBI certification
Provepharm receives FDA marketing approval in US for BLUDIGO, its indigo carmine injection drug product
Endo Tools Therapeutics receives positive opinion from French High Authority for Health on Forfait Innovation scheme to treat patients with diabetes
Deciphera obtient l’autorisation de la commission européenne pour le QINLOCK® (RIPRETINIB) en traitement de quatrième ligne des tumeurs stromales gastro-intestinales (GIST)
Amolyt Pharma obtient la désignation de médicament orphelin de la FDA pour l’AZP-3601 pour le traitement potentiel de l’hypoparathyroïdie
